Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS
Phase 1 / Phase 2 · 3 sites
Search the registry
2,585 studies found
Phase 1 / Phase 2 · 3 sites
Phase 3 · 1 site
Phase 1 / Phase 2 · 1 site
Phase 1 · 1 site
Potential match only. Final eligibility is determined by the study team.